2-Acetylbutyrolactone Market to Reach 150 Million USD in 2025 Amidst Rapid Capacity Expansions in China

Global 2-Acetylbutyrolactone Market to Reach 150 Million USD in 2025 Amidst Rapid Capacity Expansions in China

December 10, 2025 – HDIN Research, a leading chemical market intelligence provider, has released its latest industry analysis on the 2-Acetylbutyrolactone (ABL) market. The report forecasts that the global market size for ABL will range between 100 million and 150 million USD in 2025. Despite a steady Compound Annual Growth Rate (CAGR) of 1.6% to 3.6% projected through 2030, the industry is facing a significant shift in supply dynamics driven by aggressive capacity expansions in China.

Product Overview and Technical Background
2-Acetylbutyrolactone (CAS No. 517-23-7), also known as alpha-acetyl-gamma-butyrolactone, is a vital organic intermediate. The mainstream production process involves the Claisen condensation of gamma-butyrolactone and ethyl acetate. This reaction occurs in the presence of strong alkaline substances, such as metallic sodium, metallic potassium, sodium ethoxide, or sodium amide, to synthesize the final product.

China currently stands as the world's largest producer and consumer of ABL. The chemical serves as a critical raw material for two primary downstream sectors: Agrochemicals and Pharmaceuticals.

Critical Applications Driving Demand
The demand for ABL is anchored by the production of Vitamin B1 and Prothioconazole.

In the agrochemical sector, ABL is essential for synthesizing Prothioconazole, a broad-spectrum triazolinthione fungicide originally launched by Bayer in 2004. Prothioconazole is widely used for disease control in cereals, wheat, and legumes. Following the expiration of Bayer's patents in China, Europe, and the US between 2015 and 2018, the generic market has expanded. Major producers of this fungicide now include Bayer, Hailir Pesticides and Chemicals, and Hefei Jiuyi Agriculture Development. Additionally, ABL is used to synthesize other fungicides like Pyrimethanil and Cyproconazole.

In the pharmaceutical sector, ABL acts as a precursor for Vitamin B1, with major manufacturers including DSM-Firmenich, JiangXi Tianxin Pharmaceutical, and Brother Enterprises. Beyond vitamins, ABL is a versatile intermediate used in the synthesis of:

Cyclopropyl methyl ketone, which is further processed into anti-AIDS drugs (Efavirenz), antipsychotics (Risperidone, Paliperidone), and anticonvulsants.
5-Chloropentan-2-One, a key intermediate for the production of Hydroxychloroquine.
Other medical applications include Chloromethiazole hydrochloride and Chloroquine.

Supply Chain Analysis: Looming Risk of Overcapacity
While demand remains stable, the supply side is witnessing unprecedented expansion. HDIN Research data highlights that total planned capacity in China currently exceeds 60,000 tons, raising concerns regarding severe market overcapacity in the coming years.

Zhejiang Realsun Chemical Co. Ltd is currently the largest manufacturer in China with a production capacity of 15,000 tons. Most other existing Chinese competitors maintain capacities below 10,000 tons. However, significant new projects are underway. JiangXi Tianxin Pharmaceutical, which established an ABL line in 2021 primarily for captive Vitamin B1 production, is constructing a new facility through its subsidiary, Ningxia Tianxin Pharmaceutical, with a massive capacity of 26,000 tons.

Similarly, Shaanxi Jinxinyi Chemical Technology, with a current capacity of 3,300 tons, announced a 3,500-ton expansion in 2024 and has a long-term goal of reaching 18,000 tons. Xinxiang Ruicheng Technology plans to quadruple its capacity from 5,000 tons to 20,000 tons, and Zhejiang Rongkai Technology Development is planning a new 16,000-ton facility.

About HDIN Research
HDIN Research is a premier market research and consulting firm providing in-depth analysis and data-driven insights across the chemical and pharmaceutical industries. We help businesses navigate complex market landscapes and make informed strategic decisions.

Media Contact:
Company Name: HDIN Research
Website: www.hdinresearch.com
Email: sales@hdinresearch.com